February 2015 Issue of ONA
In the News
Treatment-resistant non-small cell lung cancer (NSCLC) responds to new drug
An oral drug called ASP8273 caused tumor shrinkage in patients in a phase I clinical trial, according to research presented at the 26th EORTC-NCI-AACR Symposium ...
Life expectancy still not used to determine aggressiveness of prostate cancer treatment
More than half of prostate cancer patients age 66 years and older have life expectancies of less than 10 years, yet half of them were ...
Navigator Notes
Oncology Patient Navigation: Bringing This Crucial Role to the Forefront
This emerging role is leading nurses toward more comprehensive patient care, improved community outreach, and a stronger voice to advocate for patients.
Features
Navigation and survivorship: Rationalizing your program costs
The cost of nonbillable nursing hours needed for these programs may hinder compliance. The right technology can link treatment silos and lower this cost.
Evolving roles for oncology nurses: Biospecimen collection
Personalized medicine is changing oncology nursing. This primer explains best practices for collecting and preparing biospecimens used to guide therapy.
Mobile support system keeps up with a younger generation of breast cancer survivors
A new digital program using a Web site and social media aims to meet the unique support needs of women younger than 40 years with ...
Quantifying mental disorders in patients with cancer
Researchers in Germany interviewed more than 2,000 patients with cancer to gather epidemiologic data on mental health of patients with cancer.
Sign Up for Free e-newsletters
ONA Articles
- Aggressive EOL Care Negatively Impacts Care Quality, Health Costs in Metastatic Lung Cancer
- Navigation at the End of Therapy: A Crucial Transition in Lymphoma Treatment
- HPV Vaccination and Anti-programmed Cell Death 1 Inhibition Improve Survival in Patients With Invasive HPV-16
- Managing Dermatologic Adverse Events in Patients Receiving Third-Generation EGFR-TKIs
- Risk of Relapse Up for Young Adults With Leukemia
- Tandem Autologous-Allogenic HCT Offers Long-Term Remission in Multiple Myeloma
- Anxiety, Depression in Prostate Cancer: Managing Psychosocial Effects in Male Patients
- Tool Addresses Well-being of Informal Caregivers of Patients With Cancer
- Hematologic Cancers: 8 Tips Oncology Nurses Should Share with Caregivers
- Acrylamide in Food and Cancer Risk (Fact Sheet)
- Use of Corticosteroids With PD-1 or PD-L1 Inhibitors Associated With Poorer Outcomes in NSCLC
- NHS, HPFS Show Regular Aspirin Use Reduced Hepatocellular Carcinoma Risk
- HPV Vaccination and Anti-programmed Cell Death 1 Inhibition Improve Survival in Patients With Invasive HPV-16
- Myelofibrosis: From Diagnosis to Early Intervention
- FDA Approves HPV Vaccine for People Through Age 45
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
| Bone Cancer | Regimens | Drugs |
| Brain Cancer | Regimens | Drugs |
| Breast Cancer | Regimens | Drugs |
| Endocrine Cancer | Regimens | Drugs |
| Gastrointestinal Cancer | Regimens | Drugs |
| Genitourinary Cancer | Regimens | Drugs |
| Gynecologic Cancer | Regimens | Drugs |
| Head and Neck Cancer | Regimens | Drugs |
| Hematologic Cancer | Regimens | Drugs |
| Lung Cancer | Regimens | Drugs |
| Other Cancers | Regimens | |
| Rare Cancers | Regimens | |
| Skin Cancer | Regimens | Drugs |